MEDAM (Menopur Retrospective Data prograM)

Ferring

Status: Completed

Conditions: Infertility, Female

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT04876300

000376

Details and patient eligibility

About

French, non-interventional, retrospective, multicentric analysis of patients who have undergone a controlled ovarian stimulation (COS) for in-vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI). The main objective is to determine the cumulative live birth rate with highly purified menotropin (HP-hMG) which is defined as the occurrence of live birth per started COS, further to transfer of fresh and frozen embryos generated from the same COS.

Enrollment: 11,488 patients

Sex: Female

Ages: 18 to 42 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient undergoing a COS with HP-hMG for IVF/ICSI cycle from a French data registry between 2009 to 2016

Exclusion criteria

• Ovulation inductions
• Intra-uterine inseminations
• Fertility preservations
• Oocyte donations

Trial design

11,488 participants in 1 patient group

Menotropin Cohort

Treatment:

Other: No intervention